about
Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent.Cystic tumors of the pancreas.Use of contrast agents in oncological imaging: magnetic resonance imaging.Contrast agents for hepatic magnetic resonance imaging.Magnetic resonance imaging in children: common problems and possible solutions for lung and airways imagingRenal artery stenosis evaluation: diagnostic performance of gadobenate dimeglumine-enhanced MR angiography--comparison with DSA.Staging cancer of the pancreasSerous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas).Intrahepatic chemotherapy for unresectable cholangiocarcinoma: review of literature and personal experience.Diffusion weighted imaging in cystic fibrosis disease: beyond morphological imaging.Grading lung neuroendocrine tumors: Controversies in search of a solution.Radiologist income, receipts, and academic performance: an analysis of many nations.Assessment of CF lung disease using motion corrected PROPELLER MRI: a comparison with CT.Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography.Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine.Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.MRI of hepatic epithelioid hemangioendothelioma (HEH).Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.Reference Values for Central Airway Dimensions on CT Images of Children and Adolescents.Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging.MRI features of primary hepatic lymphoma.Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms.Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings.Salivary Gland Involvement in Patients with Chronic PancreatitisECONOMIC EVALUATION OF INTRAVENOUS IODINATED CONTRAST MEDIA IN ITALYDiffusion-weighted magnetic resonance imaging in the prediction and assessment of chemotherapy outcome in liver metastasesOctreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trialRole of magnetic resonance in characterising extrahepatic cholangiocarcinomasVanishing bile duct syndrome and inflammatory pseudotumor associated with a case of anabolic steroid abuseRole of echocardiography and cardiac MRI in depicting morphological and functional imaging findings useful for diagnosing hypertrophic cardiomyopathySolid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administrationDetection of liver metastases on gadobenate dimeglumine-enhanced MRI: systematic review, meta-analysis, and similarities with gadoxetate-enhanced MRI
P50
Q30378880-8843AE09-80B5-40D8-AA9B-A06BD8192EF7Q30502841-897C52DD-F817-4428-A196-ABF2C81DFC81Q30669419-56EC2E19-109A-45F5-AF72-3977C03B1B9BQ34925635-228214D2-DB36-41C5-A286-8E1F3C319D1DQ36339145-9AB24103-3E30-4F23-B04C-CDD428E6452CQ37121430-ECBABAB8-8FB4-4C32-86AC-C697C06F34C6Q37794484-B1DB50ED-41DF-47BA-88FE-2998D67A169CQ38425475-3EB19A75-5F9B-40DB-BC69-E8FA17F5B7CEQ38607490-324ACCAE-670F-4FAF-9584-C0FD8EB2D3B1Q38908611-91CADEE1-292D-48DC-9FC3-F2BCE5EA6BB4Q38954551-22C63EDE-A3E4-49D1-96DB-4E0B38F4B7BFQ39961321-EA23C554-DF28-4C94-A18F-FBEBEE66817AQ41708366-B49A0AC2-EB6F-4ECA-BCA9-88A058788F9EQ42938258-AEAE6F0B-8D57-47DB-81FB-6C932CAC7063Q43527465-92EDAF7A-90AE-46DA-A4E1-D768C11F10B9Q43806737-C67E6182-B7AC-4E7E-ADC6-D6FFD1D4CB0BQ44186458-C128CAF6-7587-4683-AF76-0B1B10328550Q44733460-AC4F8C20-EDF7-4B67-9A19-7E44ED841ECAQ45061655-1BC1499A-0F33-4D60-9E9B-85F2F285BA69Q46546726-16DE1A7C-07BC-4042-883B-D181A2773A59Q47277182-E9D08CA6-FC97-40EE-8001-B3D59CF3104AQ47826364-61D602EE-6B31-4621-9566-137ABA1E938FQ49826898-F841501E-0DCD-4439-8632-147F9BB059FAQ53066783-19CC58B6-FBAB-4D18-9F7D-9297B528F48FQ54163867-A4AFE649-CCF6-41AD-B81F-F721D6FB0F11Q57951226-601BE70F-514C-4A41-BD5A-5D5CCD2C2EF2Q61660449-6D52C235-DCBE-499C-94D8-8017C21A8FC2Q63366773-4CB3A353-85B5-40F0-9DA9-261AFD370084Q64073930-6BCD82D2-97CF-420B-B08C-64E202FF88D8Q79738349-736745A2-A440-491B-A5BD-E724D970A8C2Q81086877-A70FE340-8ED6-4445-A96A-4A601AEED4CEQ82086317-33908105-179A-4615-916F-1027906B2993Q82576208-3C1245DF-A1A7-4029-A927-B4C0F898E872Q92641860-FD384F90-5CEA-4747-86FE-153BE9E4E97F
P50
description
researcher ORCID ID=0000-0003-3144-2963
@en
name
Giovanni Morana
@en
Giovanni Morana
@nl
type
label
Giovanni Morana
@en
Giovanni Morana
@nl
prefLabel
Giovanni Morana
@en
Giovanni Morana
@nl
P106
P31
P496
0000-0003-3144-2963